EP3454877A4 - Zusammensetzungen und verfahren zur hemmung der biofilmabscheidung und -produktion - Google Patents

Zusammensetzungen und verfahren zur hemmung der biofilmabscheidung und -produktion Download PDF

Info

Publication number
EP3454877A4
EP3454877A4 EP18799416.5A EP18799416A EP3454877A4 EP 3454877 A4 EP3454877 A4 EP 3454877A4 EP 18799416 A EP18799416 A EP 18799416A EP 3454877 A4 EP3454877 A4 EP 3454877A4
Authority
EP
European Patent Office
Prior art keywords
biofilms
compositions
production
methods
inhibiting deposition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP18799416.5A
Other languages
English (en)
French (fr)
Other versions
EP3454877A1 (de
Inventor
Henry Daniell
Hyun Koo
Robert J. Gambogi
Anthony R. GEONNOTTI
Latrisha K. PETERSEN
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Pennsylvania Penn
Kenvue Brands LLC
Original Assignee
Johnson and Johnson Consumer Inc
University of Pennsylvania Penn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/US2017/032437 external-priority patent/WO2017197280A1/en
Application filed by Johnson and Johnson Consumer Inc, University of Pennsylvania Penn filed Critical Johnson and Johnson Consumer Inc
Publication of EP3454877A1 publication Critical patent/EP3454877A1/de
Publication of EP3454877A4 publication Critical patent/EP3454877A4/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01084—Glucan 1,3-alpha-glucosidase (3.2.1.84), i.e. mutanase
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A61K38/1729—Cationic antimicrobial peptides, e.g. defensins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01011—Dextranase (3.2.1.11)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Biochemistry (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Confectionery (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
EP18799416.5A 2017-05-12 2018-05-14 Zusammensetzungen und verfahren zur hemmung der biofilmabscheidung und -produktion Withdrawn EP3454877A4 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US2017/032437 WO2017197280A1 (en) 2016-05-12 2017-05-12 Compositions and methods for inhibiting biofilm deposition and production
PCT/US2018/032549 WO2018209345A1 (en) 2017-05-12 2018-05-14 Compositions and methods for inhibiting biofilm deposition and production

Publications (2)

Publication Number Publication Date
EP3454877A1 EP3454877A1 (de) 2019-03-20
EP3454877A4 true EP3454877A4 (de) 2019-12-04

Family

ID=65365391

Family Applications (1)

Application Number Title Priority Date Filing Date
EP18799416.5A Withdrawn EP3454877A4 (de) 2017-05-12 2018-05-14 Zusammensetzungen und verfahren zur hemmung der biofilmabscheidung und -produktion

Country Status (4)

Country Link
EP (1) EP3454877A4 (de)
JP (1) JP2020519560A (de)
AU (1) AU2018266241A1 (de)
WO (1) WO2018209345A1 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113025447B (zh) * 2021-02-05 2022-03-11 广东省科学院生物工程研究所 一种清除细菌生物被膜的组合物及其应用
EP4447989A1 (de) * 2021-12-16 2024-10-23 Novozymes A/S Mundpflegezusammensetzung mit enzymen
US20250311734A1 (en) 2022-05-14 2025-10-09 Novozymes A/S Compositions and Methods for Preventing, Treating, Suppressing and/or Eliminatting Phytopathogenic Infestations and Infections

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0812541A (ja) * 1994-06-29 1996-01-16 Lion Corp 口腔用組成物
JP2002020254A (ja) * 2000-07-07 2002-01-23 Lion Corp 歯磨剤組成物
WO2005006872A1 (en) * 2003-07-11 2005-01-27 Colgate-Palmolive Company Chewable antiplaque confectionery dental composition

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60130509A (ja) * 1983-12-20 1985-07-12 Lion Corp 口腔用組成物
JP3440694B2 (ja) * 1996-05-16 2003-08-25 ライオン株式会社 口腔用組成物
US6669929B1 (en) * 2002-12-30 2003-12-30 Colgate Palmolive Company Dentifrice containing functional film flakes
US9271904B2 (en) * 2003-11-21 2016-03-01 Intercontinental Great Brands Llc Controlled release oral delivery systems
US20060263306A1 (en) * 2005-05-19 2006-11-23 Pauline Pan Compositions having improved substantivity
US20070140990A1 (en) * 2005-12-21 2007-06-21 Nataly Fetissova Oral Compositions Comprising Propolis
BR112012002992A2 (pt) * 2009-08-12 2016-04-19 Colgate Palmolive Co composição para cuidado oral, composição, método para inibir formação de biopelícula e/ou degradar uma biopelícula em um paciente, uso de um sesquiterpenóide.
US8900557B2 (en) * 2010-12-30 2014-12-02 Jr Chem, Llc Dental cleaning composition
US20120315260A1 (en) * 2011-06-13 2012-12-13 Svetlana A. Ivanova Compositions and Methods to Prevent and Treat Biofilms
US9125841B2 (en) * 2013-02-26 2015-09-08 Johnson & Johnson Consumer Inc. Oral care compositions

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0812541A (ja) * 1994-06-29 1996-01-16 Lion Corp 口腔用組成物
JP2002020254A (ja) * 2000-07-07 2002-01-23 Lion Corp 歯磨剤組成物
WO2005006872A1 (en) * 2003-07-11 2005-01-27 Colgate-Palmolive Company Chewable antiplaque confectionery dental composition

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2018209345A1 *

Also Published As

Publication number Publication date
AU2018266241A1 (en) 2019-01-03
WO2018209345A1 (en) 2018-11-15
JP2020519560A (ja) 2020-07-02
EP3454877A1 (de) 2019-03-20

Similar Documents

Publication Publication Date Title
EP3706784A4 (de) Zusammensetzungen und verfahren zur herstellung von t-zellen
EP3493827A4 (de) Zusammensetzungen und verfahren für die immuntherapie
MA46427A (fr) Compositions d'oligonucléotides et procédés associés
EP3405577A4 (de) Zusammensetzungen und verfahren zur hemmung des faktors d
MA45270A (fr) Compositions d'oligonucléotides et procédés associés
EP3294865A4 (de) Verfahren zur herstellung von epimerasen und benzylisochinolinalkaloiden
EP3259124A4 (de) Widerstandsfähige fussbodenprodukte und verfahren zur herstellung davon
EP3332774A4 (de) Zusammensetzung für weichkapselbeschichtung
EP3464424A4 (de) Pai-basierte beschichtungszusammensetzungen
EP3408326A4 (de) Elastomere artikel, zusammensetzungen und verfahren zu deren herstellung
EP3443094A4 (de) Verfahren zur reduzierung der c9orf72-expression
EP3289087A4 (de) Verfahren und zusammensetzungen zur herstellung von verkürzten maispflanzen
HUE069896T2 (hu) Eljárás fémfelületek nikkelmentes foszfátozására
EP3389657A4 (de) Verfahren zur behandlung von hyperalgesie
EP3349743A4 (de) Verfahren und zusammensetzungen zur hemmung der dcn1-ubc12-interaktion
GB2575000B (en) Prevention of biofilm formation
MA42829A (fr) Compositions dérivées de placenta et procédés pour les produire
EP3365403A4 (de) Kobaltnhibitorkombination zur verbesserten biegebildung
SI3573620T1 (sl) Sestavki za zdravljenje hipertenzije
EP3397399A4 (de) Verfahren zur kontinuierlichen generativen fertigung
EP3735457A4 (de) Zusammensetzungen und verfahren zur herstellung von megakaryozyten
EP3370962A4 (de) Zusammensetzungen und verfahren zur generativen fertigung
EP3619334A4 (de) Verfahren zur abscheidung von nanoverzwillingten nickel-molybdän-wolfra-mlegierungen
DK3630744T3 (da) Pyrazol-magl-inhibitorer
EP3604462A4 (de) Beschichtungszusammensetzung

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20181212

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

A4 Supplementary search report drawn up and despatched

Effective date: 20191104

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 38/08 20190101ALI20191028BHEP

Ipc: A61K 38/04 20060101ALI20191028BHEP

Ipc: A61K 38/00 20060101AFI20191028BHEP

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20200603